OCUL — Ocular Therapeutix Balance Sheet
0.000.00%
- $1.23bn
- $902.46m
- $63.72m
Annual balance sheet for Ocular Therapeutix, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Cash and Short Term Investments | 228 | 164 | 102 | 196 | 392 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 12.3 | 21.1 | 21.3 | 26.2 | 32.4 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 246 | 191 | 130 | 232 | 441 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 13.9 | 11.8 | 17.9 | 18.2 | 15.3 |
Other Long Term Assets | |||||
Total Assets | 262 | 205 | 149 | 252 | 458 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 26.7 | 26.3 | 31.4 | 34.9 | 41.4 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 186 | 117 | 114 | 161 | 143 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 76.1 | 88 | 35.4 | 91.1 | 315 |
Total Liabilities & Shareholders' Equity | 262 | 205 | 149 | 252 | 458 |
Total Common Shares Outstanding |